Growth Stage

Eliminate Snoring With a Simple Mouthguard.

Eliminate Snoring With a Simple Mouthguard.


Raised to Date: Raised: $359,340

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Preferred

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Rolling Commitments ($USD)

Reporting Date


Days Remaining
% of Min. Goal
% of Max. Goal
Likelihood of Max
Avg. Daily Raise


# of Investors


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Fitness & Wellness

Tech Sector



Carson City, Nevada

Who Should Be Interested:
Do you, or does someone you know (and sleep with), snore? Are you tired of being woken up by chainsaw rumbles each night? If this sounds like you, then Zyppah could be the investment you’ve been waiting for. Zyppah is an anti-snoring device that will help you finally get some sleep again -- without those earthquake-like snoring interruptions.

The Company:
Zyppah is here to help with your snore. It’s an oral hybrid mouthpiece that combines a patented tongue strap, called the Tongue Elastic, with traditional mouthpiece technology. The strap supports the tongue and keeps it from falling backwards into your airway, while the traditional technology brings the jaw forward. The best part? For the majority of clients, it’s not only comfortable, but it completely eliminates snoring -- even within the first night of use! Zyppah is the only hybrid mouthpiece of its kind in the US, and right now they are available to buy online. However, Zyppah anticipates FDA approval for over-the-counter sales in the next year, which means the produce would be sold in places like Amazon, Costco, and Walmart. So far, the company’s sold almost 140,000 units and collected $13M in revenue in 2017, and they have more than 20,000 unique visitors to their site per week. The device is made entirely in the US for $18 and retails for $100.

The Bottom Line:
100 million Americans snore a year, and 30-40 million of them develop sleep apnea. Zyppah can help these people (and their partners!) find the much-needed sleep they deserve. If they can capture even 10% of the snoring market, that would lead to 10 million appliances sold and $1B in sales. Zyppah can help you turn a profit….and sleep soundly while doing so.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
ZYPPAH 08/21/2024 Dealmaker Securities $25,000,000 $83,200 Equity - Common Active RegCF
ZYPPAH 06/29/2018 Wefunder $80,000,000 $359,340 Equity - Preferred Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
ZYPPAH on Wefunder
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $80,000,000
Price per Share: $10.00

Follow company

Follow ZYPPAH on Wefunder

Buy ZYPPAH's Deal Report

Warning: according to the close date for this deal, ZYPPAH may no longer be accepting investments.

ZYPPAH Deal Report

Get KingsCrowd’s comprehensive report on ZYPPAH including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether ZYPPAH is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the ZYPPAH deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge